Matthew Gline Roivant Sciences Ltd. (ROIV) insider trading activity

ROIV Quotes by TradingView

Matthew Gline is CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 17.3 Million shares of ROIV, which is worth approximately $183 Million. The most recent transaction as insider was on Apr 25, 2022, when has been sold 8,509 shares (Common Shares) at a price of $3.84 per share, resulting in proceeds of $32,675. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.3M
0.19% 3M change
1629.92% 12M change
Total Value Held $183 Million

Matthew Gline Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 25 2022
SELL
Open market or private sale
$32,675 $3.84 p/Share
8,509 Reduced 0.6%
1,404,448 Common Shares
Mar 30 2022
SELL
Payment of exercise price or tax liability
$119,704 $4.74 p/Share
25,254 Reduced 1.76%
1,412,957 Common Shares
Mar 30 2022
SELL
Open market or private sale
$163,040 $4.84 p/Share
33,686 Reduced 2.29%
1,438,211 Common Shares
Mar 25 2022
SELL
Open market or private sale
$179,053 $5.06 p/Share
35,386 Reduced 2.35%
1,471,897 Common Shares
Mar 18 2022
SELL
Open market or private sale
$420,691 $5.13 p/Share
82,006 Reduced 5.16%
1,507,283 Common Shares
Mar 07 2022
SELL
Open market or private sale
$509,628 $5.52 p/Share
92,324 Reduced 5.49%
1,589,289 Common Shares
MG

Matthew Gline

CEO
London, X0

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ROIV